Effects of variable alphaprodine dose levels on arterial blood gases in rhesus monkeys.
The administration of alphaprodine submucosally in doses of 0.5, 1.0, and 1.5 mg/kg to ketaminized rhesus monkeys resulted in Po(2) levels significantly lower than those observed for controls (ketamine only) at the 10 min level. There was a significant increase in Po(2) levels between the 10 and 20 min intervals, thereafter, Po(2) levels returned toward normal and were not statistically different from baseline. Higher alphaprodine doses (1.0 and 1.5 mg/kg) resulted in a non-significant increase in Pco(2) values. Monitoring Po(2) levels during sedation seems preferable to monitoring Pco(2) in view of the findings of this study.
D000522:Alphaprodine / Q000008:administration & dosage*; D000818:Animals; D002245:Carbon Dioxide / Q000097:blood*; D007649:Ketamine; D008253:Macaca mulatta; D009061:Mouth Mucosa; D010100:Oxygen / Q000097:blood*; D010313:Partial Pressure
D000522:Alphaprodine; D002245:Carbon Dioxide; D007649:Ketamine; D010100:Oxygen